Final CABP and HABP-VABP guidances from FDA; EU seeks to accelerate access to medicines Dear All, Some regulatory updates today. From FDA, we have final versions of their CABP and HABP-VABP guidance documents. My initial review suggests no big Read More » 25 June 2020 No Comments